Prostate cancer marker test: what to know

The marker most often discussed in prostate care is prostate-specific antigen, or PSA. The prostate normally releases PSA, and levels can change for reasons other than cancer, including benign prostate enlargement, inflammation, infection, ejaculation, or recent procedures. A low result does not remove every possibility, and a raised result is not proof of cancer.

Clinicians look at the result alongside age, symptoms, examination findings, previous results, medicines, and family history. They may consider the direction of change over time rather than one isolated reading. If concern remains, imaging or a biopsy may be discussed.

Ask whether the test should be repeated and whether anything could have influenced the result. Tell the clinician about urinary infection symptoms, recent catheter use, prostate procedures, and medicines. Difficulty passing urine can reflect prostate enlargement or another problem and should be assessed rather than interpreted from a marker result alone.

If cancer is diagnosed, marker testing may help monitor how the disease responds to treatment or whether further assessment is needed. Your team will explain the testing schedule and what change would prompt action.

Arrange prompt medical assessment for fever with painful urination, inability to pass urine, heavy blood in the urine, or severe pelvic pain. Seek emergency help for confusion, collapse, or severe weakness. A marker test is not a substitute for urgent care when symptoms are intense or rapidly worsening.

Which marker is being measured, and why now? Could infection, medication, or a recent procedure affect the result? What is the next step if it is raised? Do I need imaging, specialist review, or a biopsy?